295.4 ๐ ็ซ ๆซ้่จ Summary
295.4.1 ๐ ไธๅฅ่ฉฑ็ธฝ็ต
ๅฟ่ๅคๅท ๅ blunt๏ผcontusion ๆๅธธ่ฆใrupture RA ๆๅธธ่ฆใvalvular TV ๆๅธธ่ฆใcoronary dissectionใaortic transection at isthmusใconduction injury๏ผvs penetrating๏ผtamponade ้ซๆญปไบก๏ผvs iatrogenic๏ผcathใpacemaker leadใTAVR๏ผ๏ผaortic transection ๅจ deceleration injury๏ผaortic isthmus๏ผโ CT angio gold standard + TEVAR first-line + esmolol BP < 120๏ผcardiac tamponade ็จ FAST ็ฏฉ โ emergent surgery๏ผpenetrating peri-arrest stab = ED thoracotomy๏ผcommotio cordis = AED + CPR life-saving๏ผiatrogenic ่็ = reverse AC + pericardiocentesis + multidisciplinaryใ
295.4.2 ๐ ๆฒป็็ฒพ่ฆ
- contusion๏ผtelemetry 24-48 h + ็ฃๆธฌ arrhythmia + supportive
- rupture / tamponade๏ผemergent surgery / pericardiocentesis
- aortic transection๏ผesmolol + nicardipine, BP < 120, HR < 60 โ TEVAR
- valvular injury๏ผsurgery (repair > replacement)
- iatrogenic๏ผreverse AC (PCC + vit K / andexanet / idarucizumab) + pericardiocentesis if tamponade
- trauma resuscitation๏ผ1:1:1 blood products + TXA + permissive hypotension
295.4.3 ๐ฏ ็ง้ซๅธซ็่ๅๆ้
- blunt cardiac contusion ๆฏๆๅธธ่ฆ blunt cardiac injury in survivors๏ผRV ๆๅธธๅๅท๏ผๆๅไฝ๏ผ
- troponin ๅจ 4-6 ๅฐๆๅพ NPV ๆ้ซ โ ๆฏ cardiac contusion ็ๆไฝณๆ้คๅทฅๅ ท
- cardiac rupture ๅคง้จๅๆญปไบก pre-hospital๏ผRA ๆๅธธ่ฆ๏ผ่ๅฃ๏ผ๏ผFAST ็ฏฉ โ ็ทๆฅๆ่ก
- aortic transection๏ผdeceleration injury ๅจ aortic isthmus๏ผligamentum arteriosum ๅบๅฎ้ป๏ผ๏ผ50% ๆญปไบก at scene
- CXR aortic transection ่ทก่ฑก๏ผwidened mediastinumใapical capใblurred aortic knobใdepressed L main bronchusใdeviation of trachea
- TEVAR > open repair for aortic transection โ ๆฏ็พไปฃ first-line๏ผlower mortality + morbidity๏ผ
- valvular injury blunt๏ผTR ๆๅธธ่ฆ๏ผ่งฃๅไฝ็ฝฎๆๆด้ฒ๏ผ๏ผaortic ๅจ 50% ้ๅคง deceleration injury
- ED thoracotomy๏ผperi-arrest stab wound ๆ some survival benefit๏ผgunshot ้ ๅพๆฅตๅทฎ
- damage control resuscitation๏ผ1:1:1 (RBC:plasma:platelets) + TXA + permissive hypotension๏ผไธ่ฆ crystalloid overload๏ผ
- iatrogenic cardiac injury ่็๏ผreverse AC๏ผ4F-PCC + vit K for warfarin๏ผandexanet alfa for Xa inhibitor๏ผidarucizumab for dabigatran๏ผ+ pericardiocentesis + emergent surgery if persistent